Rituximab and Ianalumab develop B cell depletion differently: Rituximab is a first line choice for CD20-driven diseases like non-Hodgkin lymphoma or RA, while Ianalumab shows promise in broader B-cell depletion and BAFF-R inhibition, such as SLE or Sjögren’s disease.
Posts by Pete Caruso
A Sjogrens trial of ianalumab (in Phase III) announced reaching primary endpoints. Ianalumab is a B-cell depletion and BAFF-R inhibition treatment. Ianalumab has the potential to become the first and only targeted treatment for Sjogrens, once its approved.
www.novartis.com/news/media-r...
At the University of Washington and University of Victoria, researchers used DNA from 852 people to train a new AI model that distinguishes ME/CFS from Long COVID with 97% accuracy, offering a potential blood test for these misunderstood illnesses.
www.biorxiv.org/content/10.1...
@davidfajgenbaum.bsky.social ME is exactly the type of challenge you are good at unraveling. Please help us fight #GreatestMEdicalScandal and find effective cures/treatments for #pwME! 🙏
The Sick Times: 'Colorado art exhibition showcases creative expressions of Long COVID, advocates for research and treatment'
'The gallery is both a stark witness to people’s lived truth with Long COVID and a bright space of creativity and community.'
thesicktimes.org/2025/05/23/c...
Please help us @latenightseth.bsky.social 🙏
NL Times: 'Muscles of long Covid patients respond differently to inactivity than healthy people'
'Researchers also saw issues when it came to energy production. This came as a result of malfunctioning mitochondria, which are the energy factories...'
nltimes.nl/2025/05/23/m...
Help us out @saquonbarkley.bsky.social! 🙏 #GoBirds
Health Rising: “Finding the Key? Could Unraveling T-cell Exhaustion Solve ME/CFS and Long COVID”
www.healthrising.org/blog/2025/05...
The Sick Times: ““Millions Missing” protest at the Capitol demands myalgic encephalomyelitis funding, social support
thesicktimes.org/2025/05/12/m...
Reminder: On May 12-13, the “International ME/CFS Conference 2025” will take place. Speakers include Carmen Scheibenbogen, David Putrino, Michael Peluso, Michael Stingl, Klaus Wirth and many more.
Registration for the livestream is still possible at events.mecfs-research.org/de/events
Great to see this paper out, showing persistent heart and lung inflammation in people with #LongCOVID, but also highlighting once again that SARS-CoV-2 is a virus that profoundly affects vascular health and that every new infection can do damage.
www.mountsinai.org/about/newsro...
Image of a woman running Thousands demand withdrawal of review article recommending exercise therapy for chronic fatigue syndrome The decision to abandon a process to re-evaluate a review recommending exercise therapy for chronic fatigue syndrome (ME/CFS) has reignited calls for the article to be withdrawn. The 2019 version of the Cochrane Library review, “Exercise therapy for chronic fatigue syndrome,” has accumulated 67 citations, according to Clarivate’s Web of Science.
Thousands demand withdrawal of review article recommending exercise therapy for chronic fatigue syndrome
Links in image:
www.cochranelibrary.com/cdsr/doi/10....
retractionwatch.com/2025/01/23/t...
Screenshot from the AMMES May email newsletter
#MEcfs #CFS
Rory Preston: Our analysis suggests Long COVID, inc. COVID-triggered ME/CFS, now ranks among the most burdensome diseases in the US — ahead of stroke, diabetes & COPD It’s a rough estimate, but the message is clear: this crisis can’t be ignored. We need to scale research, funding & support
Rory Preston: Our analysis suggests Long COVID, inc. COVID-triggered ME/CFS, now ranks among the most burdensome diseases in the US — ahead of stroke, diabetes & COPD
It’s a rough estimate, but the message is clear: this crisis can’t be ignored.
We need to scale research, funding & support
One of my recent articles published in Frontiers in Neurology just reached a new impact milestone. Here is the link if you would like to read our study
Mijn Laatste artikel over post COVID bereikte een mijlpaal!
doi.org/10.3389/fneu...
Preprint: MedRxiv Toward a Disease Module for ME/CFS: A Network-Based Gene Prioritization — Paolo Maccallini "Enrichment analysis identified significant overlaps with sphingolipid metabolism and signaling, and energy-related pathways. Heme degradation, TP53-regulated metabolic genes, and thermogenesis were also identified as possibly contributing to the pathogenesis of ME/CFS."
Toward a Disease Module for ME/CFS: A Network-Based Gene Prioritization
www.medrxiv.org/content/10.1...
Screenshot is from the latest Science for ME weekly update
#MEcfs #CFS
To the vaxx-and-relax crowd: you’re not out of the woods.
There are 200+ symptoms of Long Covid. Vaccines help reduce some risks but not neurological or vascular damage.
A paper on this was published in January and It was buried.
“We put men on the moon decades ago, but women are still dying from severe nausea and vomiting during pregnancy,”
@lastweektonight.com @thedailyshow.com @weeklyshowpodcast.bsky.social 👀 What would Jo(h)n do?
A black background with neon purple and turquoise gaming-esque framing features photos of John Oliver and Jon Stewart facing off. White text reads, “The Sick Times. The history of ME deserves a late-night spotlight. That’s why we started the #JohnVsJonVsME campaign. by Eliza Charley, Emily Fraser, Julie, Katie Klocksin, Melissa Mazur, María Richardson.”
White text inside a neon colored speech bubble reads, "Medical professionals don’t just neglect people with ME but often only offer them harmful treatments like cognitive behavioral therapy or graded exercise therapy. COVID-19 has added millions of new people with ME to the millions already sick, making coverage of this scandal imperative now more than ever." - #JohnVsJonVsME Core Planning Group: Eliza Charley, Emily Fraser, Julie, Katie Klocksin, Melissa Mazur, and María Richardson
In a crisis-filled world, breaking through the noise requires creativity, strategy — and, occasionally, a really good meme. This is why the #JohnVsJonVsME campaign began. bit.ly/4hTwUxa
Yahoo News Canada: 'The pandemic didn't end for this P.E.I. woman, who wants more support for those with long COVID'
"It's like you're a battery that doesn't charge all the way," the Summerside resident said.
ca.news.yahoo.com/pandemic-did...
🚨 BREAKING: Long COVID research grants rescinded earlier this week have been restored, according to researchers & patient reps. Advocates organized quickly yesterday in response to the news, helping reverse the decision.
Exclusive in @thesicktimes.bsky.social
thesicktimes.org/2025/03/28/u...
NIH RECOVER cuts have started. There’s still time to contact Congress and ask them to stop the Long COVID Recover cuts. See easy toolkit by Long COVID Campaign to send a message.
#NotLongCOVIDcuts
bsky.app/profile/lcca...
“We already have a division at NIH devoted to study Long COVID and figure out cures...creating a CDC agency for vaccine injuries and also Lyme disease…more and more people are suffering from these diseases” - RFK Jr.
Chris Cuomo didn't ask about the Long COVID Recover cuts announced this week.
❤️
Nipocalimab (mAb) Phase 3 Clinical Trial is now recruiting for Sjogren's Disease in USA, UK, Japan, and Taiwan
For cities/locations, see the clinical trials link.
www.clinicaltrials.gov/study/NCT067...
Sjogren's Disease News: Nipocalimab investigational treatment has been granted FDA breakthrough therapy designation and Fast Track designation.
Nipocalimab is a fully human mAb that targets the neonatal crystallizable fragment receptor (FcRn).
#Sjogrens
www.jnj.com/media-center...
What if something as simple as walking across the room became impossible? That’s was reality for years. Once healthy& active,I’m now housebound, struggling with fatigue, brain fog, pain, heart palpitations, and breathlessness. We need research & awareness. #LongCovidAwarenessDay